PACS Group (PACS) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

PACS Group

NYSE•Healthcare•Medical Care Facilities

$43.67+1.17(0.03%)Pre-market

Market Cap

$6.65B

P/E

24.7x

P/S

1.2x

P/B

6.0x

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

How this company scores

ExcellentMetricSide Score: 86/100

Strongest: Growth (23/25); weakest: Profitability (18/25).

Profitability18/25

Growth23/25

Balance Sheet & Red Flags23/25

Cash & Earnings Quality22/25

Strengths

Growing revenueHigh ROERising earningsLow leverage

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 24.7x5y range 16.2x – 49.7x

Currently near its 7-quarter median.

P/S · 1.2x5y range 0.4x – 1.2x

Currently above its 7-quarter median.

P/B · 6.0x5y range 2.3x – 23.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Share Dilution

Watch

Shares outstanding rose 3.3% — mild dilution. Compare to earnings growth to assess the net per-share impact.

Price & Volume

Market Cap $6.65B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $5.55B
Q. Revenue: $1.43B
TTM EBITDA: $478.30M
TTM Op. Income: $410.32M
Q. Op. Income: $109.33M
TTM Net Income: $269.17M
Q. Net Income: $76.37M
EPS: $0.48
Shares Out.: $158.11M

$5.55B in TTM revenue grew 16.6% YoY, reaching $1.43B last quarter. TTM EBITDA of $478.30M and TTM operating income of $410.32M show growth is flowing through to the bottom line. TTM net income of $269.17M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 23.7%
EBITDA Margin: 9.1%
Op. Margin: 7.7%
Net Margin: 5.3%

Op. margin of 7.7% is up 1.5% YoY — cost efficiency is improving. Net margin at 5.3% and gross margin of 23.7% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 25% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 24.7x
P/S Ratio: 1.2x
P/B Ratio: 6.0x

At 24.7x P/E, the stock trades within typical market levels. P/S of 1.2x and P/B of 6.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 19% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.66B
Cash: $164.45M
Long-Term Debt: $238.71M
Book Value: $1.11B
D/E Ratio: 0.2
Debt/EBITDA: 1.8

With $5.66B in assets and $238.71M in long-term debt, D/E is 0.2and book value is $1.11B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 7 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $135.51M
TTM Free Cash Flow: $455.78M
FCF Margin: 8.2%
FCF / Net Income: 1.7

TTM FCF of $455.78M on $135.51M in operating cash flow. The FCF / Net Income ratio of 1.7x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.